Lyra Therapeutics, Inc. (LYRA)
OTCMKTS · Delayed Price · Currency is USD
0.7100
-0.0400 (-5.33%)
At close: Apr 28, 2026
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $1.33 million as of April 28, 2026. Its market cap has decreased by -80.23% in one year.
Market Cap
1.33M
Enterprise Value
15.70M
Revenue
398.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.71
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from 230.14M to 1.33M, a decrease of -99.42%. That is a compound annual growth rate of -57.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1.26M | -76.95% |
| Dec 31, 2025 | 5.47M | -59.54% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| inTerra Resources | 1.47M |
| Protagenic Therapeutics | 1.47M |
| Neon Bloom | 1.46M |
| CERo Therapeutics Holdings | 1.30M |
| LakeShore Biopharma | 1.24M |
| Abpro Holdings | 1.16M |
| Evofem Biosciences | 1.15M |
| Windtree Therapeutics | 1.12M |